Literature DB >> 22050439

Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation.

Sang-Ho Choi1, Saba Aid, Hyung-Wook Kim, Sharon H Jackson, Francesca Bosetti.   

Abstract

Like macrophages, microglia are functionally polarized into different phenotypic activation states, referred as classical and alternative. The balance of the two phenotypes may be critical to ensure proper brain homeostasis, and may be altered in brain pathological states, such as Alzheimer's disease. We investigated the role of NADPH oxidase in microglial activation state using p47(phox) and gp91(phox) -deficient mice as well as apocynin, a NADPH oxidase inhibitor during neuroinflammation induced by an intracerebroventricular injection of LPS or Aβ₁₋₄₂. We showed that NADPH oxidase plays a critical role in the modulation of microglial phenotype and subsequent inflammatory response. We demonstrated that inhibition of NADPH oxidase or gene deletion of its functional p47(phox) subunit switched microglial activation from a classical to an alternative state in response to an inflammatory challenge. Moreover, we showed a shift in redox state towards an oxidized milieu and that subpopulations of microglia retain their detrimental phenotype in Alzheimer's disease brains. Microglia can change their activation phenotype depending on NADPH oxidase-dependent redox state of microenvironment. Inhibition of NADPH oxidase represents a promising neuroprotective approach to reduce oxidative stress and modulate microglial phenotype towards an alternative state. Published 2011. This article is a US Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22050439      PMCID: PMC3386526          DOI: 10.1111/j.1471-4159.2011.07572.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  33 in total

1.  Microglia proliferation is regulated by hydrogen peroxide from NADPH oxidase.

Authors:  Palwinder K Mander; Aiste Jekabsone; Guy C Brown
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

2.  The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins.

Authors:  P J Harrison; P R Heath; S L Eastwood; P W Burnet; B McDonald; R C Pearson
Journal:  Neurosci Lett       Date:  1995-11-24       Impact factor: 3.046

3.  Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species.

Authors:  Liya Qin; Yuxin Liu; Cynthia Cooper; Bin Liu; Belinda Wilson; Jau-Shyong Hong
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

4.  Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice.

Authors:  K A Jackman; A A Miller; T M De Silva; P J Crack; G R Drummond; C G Sobey
Journal:  Br J Pharmacol       Date:  2009-01-23       Impact factor: 8.739

5.  Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus.

Authors:  Qun Wang; Kenneth D Tompkins; Agnes Simonyi; Ronald J Korthuis; Albert Y Sun; Grace Y Sun
Journal:  Brain Res       Date:  2006-05-02       Impact factor: 3.252

6.  Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein.

Authors:  Laibaik Park; Ping Zhou; Rose Pitstick; Carmen Capone; Josef Anrather; Erin H Norris; Linda Younkin; Steven Younkin; George Carlson; Bruce S McEwen; Costantino Iadecola
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-17       Impact factor: 11.205

Review 7.  Glial reactions in Parkinson's disease.

Authors:  Patrick L McGeer; Edith G McGeer
Journal:  Mov Disord       Date:  2008-03-15       Impact factor: 10.338

Review 8.  Heterogeneity of microglial activation in the innate immune response in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-05       Impact factor: 4.147

Review 9.  NADPH oxidase as a therapeutic target in Alzheimer's disease.

Authors:  Michelle L Block
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

10.  The p47phox mouse knock-out model of chronic granulomatous disease.

Authors:  S H Jackson; J I Gallin; S M Holland
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  90 in total

Review 1.  NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.

Authors:  Hui-Ming Gao; Hui Zhou; Jau-Shyong Hong
Journal:  Trends Pharmacol Sci       Date:  2012-04-11       Impact factor: 14.819

Review 2.  Microglia antioxidant systems and redox signalling.

Authors:  F Vilhardt; J Haslund-Vinding; V Jaquet; G McBean
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

3.  Inhibition of NOX2 signaling limits pain-related behavior and improves motor function in male mice after spinal cord injury: Participation of IL-10/miR-155 pathways.

Authors:  Boris Sabirzhanov; Yun Li; Marino Coll-Miro; Jessica J Matyas; Junyun He; Alok Kumar; Nicole Ward; Jingwen Yu; Alan I Faden; Junfang Wu
Journal:  Brain Behav Immun       Date:  2019-02-23       Impact factor: 7.217

Review 4.  The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease.

Authors:  Marina A Lynch
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

Review 5.  Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury.

Authors:  Alan I Faden; Junfang Wu; Bogdan A Stoica; David J Loane
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

Review 6.  NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair?

Authors:  Evan A Bordt; Brian M Polster
Journal:  Free Radic Biol Med       Date:  2014-08-01       Impact factor: 7.376

7.  Oligomeric Aβ-induced microglial activation is possibly mediated by NADPH oxidase.

Authors:  Juan Li; Jing Yu Yang; Xue Chun Yao; Xue Xue; Qing Chun Zhang; Xiao Xiao Wang; Ling Ling Ding; Chun Fu Wu
Journal:  Neurochem Res       Date:  2012-12-11       Impact factor: 3.996

8.  An association between mitochondria and microglia effector function. What do we think we know?

Authors:  G Jean Harry; Gabrielle Childers; Sahana Giridharan; Irisyunuel Lopez Hernandes
Journal:  Neuroimmunol Neuroinflamm       Date:  2020-06-16

9.  Reducing age-dependent monocyte-derived macrophage activation contributes to the therapeutic efficacy of NADPH oxidase inhibition in spinal cord injury.

Authors:  Bei Zhang; William M Bailey; Anna Leigh McVicar; Andrew N Stewart; Amy K Veldhorst; John C Gensel
Journal:  Brain Behav Immun       Date:  2018-11-16       Impact factor: 7.217

Review 10.  The role of glutamate and the immune system in organophosphate-induced CNS damage.

Authors:  Arik Eisenkraft; Avshalom Falk; Arseny Finkelstein
Journal:  Neurotox Res       Date:  2013-03-27       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.